Kenya Offers Free 6-Month HIV Prevention Shot to Thousands

Thousands of Kenyans now have access to a revolutionary HIV prevention tool that requires just two shots per year instead of daily pills. Health authorities began rolling out lenacapavir this week, offering the long-acting injectable free of charge at public health facilities across priority counties.

The timing couldn't be more critical. Kenya records thousands of new HIV infections each year, with young people aged 15 to 24 facing the highest risk. 1.4 million Kenyans currently live with HIV.

"Today is a moment of hope for thousands of Kenyan families," Health Minister Aden Duale announced Thursday at the launch event in Nairobi. The drug, nicknamed LEN, earned the title "Breakthrough of the Year" from Science magazine in 2024.

Here's how it works: healthcare providers inject lenacapavir just below the skin in the lower abdomen or thighs. One shot provides six months of protection against HIV infection. Pregnant and breastfeeding mothers can safely use the treatment, and the government has systems in place to monitor any side effects.

Kenya received its first batch of 21,000 doses last week through a partnership with manufacturer Gilead Sciences and the Global Fund to Fight AIDS. Another 12,000 doses arrive by April, with an additional 25,000 doses coming from the United States government to support the rollout.

The drug passed rigorous safety checks. The U.S. Food and Drug Administration approved it in June 2025, and the World Health Organization released usage guidelines at a major AIDS conference in Rwanda this past July.

The Ripple Effect

Kenya joins a small group of African nations leading the charge on this innovation. South Africa, Eswatini, and Zambia started administering lenacapavir in December 2025. Zimbabwe launched its program just last week, targeting more than 46,000 high-risk individuals.

The impact extends beyond individual protection. By dramatically simplifying HIV prevention from daily pills to twice-yearly shots, lenacapavir removes major barriers that have kept vulnerable populations from consistent protection. People who struggled with daily medication schedules now have a realistic prevention option.

Minister Duale emphasized that expanding these innovative prevention tools is essential to reversing transmission trends and protecting the country's most vulnerable communities. For a nation where young people still face significant infection risk, this represents renewed strength in the fight against HIV.

This rollout gives Kenya's healthcare system a powerful new weapon in a decades-long battle, offering hope that the next generation might finally see an end to new HIV infections.